Advances in early detection and auxiliary diagnostic technologies of pancreatic cancer
Pancreatic cancer is a highly malignant digestive system tumor with a mere 9%5-year survival rate.In recent years,an alarming upward trajectory in both the incidence and mortality rates of pancreatic cancer appears,with a noticeable trend toward affecting a younger population.Screening high-risk individuals emerges as an effective measure to enhance therapeutic outcomes and patient prognosis.Liquid biopsy,as a non-invasive detection method,proves invaluable in identifying circulating tumor cells,circulating tumor genes,exosomes,and more,facilitating auxiliary tumor diagnosis.Liquid biopsy stands out due to its accessibility and capability for real-time monitoring of tumor evolution.This article aims to provide a comprehensive overview of the risk factors associated with pancreatic cancer,coupled with in-sights into auxiliary diagnostic techniques and novel markers based on various sample types relevant to pan-creatic cancer.